Perspective Therapeutics CATX
NYSE CATX
$2.67 +0.05 (+1.91%)
As of: Sep 30, 2026 · 2:30 PM EDT

Perspective Therapeutics (CATX) Non-Current Assets (2011 - 2026)

Updated

Perspective Therapeutics (CATX) posted Non-Current Assets of $150.5 million for Q2 2026, up 31.1% from $114.77 million a year earlier and up 11.1% from the prior quarter.

Analysis

Perspective Therapeutics (CATX) Non-Current Assets (2011 - 2026) Analysis & Trends

At the end of FY2025, Perspective Therapeutics' Non-Current Assets came in at $118.58 million, up 7.9% from FY2024.

  • Annual Non-Current Assets shows a five-year compound annual growth rate of 106.1% (FY2020 to FY2025).
  • In prior years, Perspective Therapeutics' Non-Current Assets was $109.94 million in FY2024 (+35.6%), $81.05 million in FY2023, $4.88 million in FY2022 and $3.11 million in FY2021 (-2.4%).
  • The Q2 2026 figure stands as the highest quarterly Non-Current Assets in data going back to Q4 2022.
  • On a year-over-year basis, Non-Current Assets has increased in each of the last three quarters, with growth averaging 22.2% over the last eight quarters.
  • The strongest year-over-year quarter for Non-Current Assets in the past five years was Q3 2024, with growth of 36.2%; the weakest was Q3 2025, with a decline of 3.8%.
  • According to Business Quant data, Non-Current Assets for the three prior quarters was $135.42 million (Q1 2026), $118.58 million (Q4 2025) and $116.33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 141.29 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 101.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 87.87 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 14.88 Bn
10 Perspective Therapeutics 298.91 Mn 298.91 Mn - 150.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 150.50 Mn
Mar 31, 2026 135.42 Mn
Dec 31, 2025 118.58 Mn
Sep 30, 2025 116.33 Mn
Jun 30, 2025 114.77 Mn
Mar 31, 2025 113.61 Mn
Dec 31, 2024 109.94 Mn
Sep 30, 2024 120.98 Mn
Jun 30, 2024 91.68 Mn
Mar 31, 2024 90.09 Mn
Dec 31, 2023 81.05 Mn
Sep 30, 2023 88.83 Mn
Jun 30, 2023 88.19 Mn
Mar 31, 2023 87.38 Mn
Dec 31, 2022 4.88 Mn
Sep 30, 2022 5.00 Mn
Jun 30, 2022 5.11 Mn
Mar 31, 2022 3.36 Mn
Dec 31, 2021 3.65 Mn
Sep 30, 2021 3.75 Mn
API Access

Perspective Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=CATX&period=max&api_key=YOUR_API_KEY